The Battle Between Influenza and the Innate Immune Response in the Human Respiratory Tract

키워드

참고문헌 (90)

1. Abrahams A, "A further investigation into influenza pneumococcal and influenza streptococcal septicaemia: epidemic inuenza pneumonia of highly fatal type and its relation to purulent bronchitis", Lancet, 1, pp.1~9 (1919)
2. Taubenberger JK, "The origin and virulence of the 1918 "Spanish" influenza virus", Proc Am Philos Soc, 150, pp.86~112 (2006)
3. Reid AH, "Origin and evolution of the 1918 "Spanish" influenza virus hemagglutiningene", Proc Natl Acad Sci U S A, 96, pp.1651~1656 (1999)
4. Tscherne DM, "An enzymatic assay for detection of viral entry", Curr Protoc Cell Biol, 26, pp.12~26 (2011)
5. Walsh JJ, "Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies", Arch Intern Med, 108, pp.376~388 (1961)
6. Hers JF, "Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza", Lancet, 2, pp.1141~1143 (1958)
7. Guarner J, "Histopathologic and immunohistochemical features of fatal inuenza virus infection in children during the 2003-2004 season", Clin Infect Dis, 43, pp.132~140 (2006)
8. Shieh WJ, "2009 pandemic inuenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States", Am J Pathol, 177, pp.166~175 (2010)
9. Uiprasertkul M, "Influenza A H5N1 replication sites in humans", Emerg Infect Dis, 11, pp.1036~1041 (2005)
10. Gu J, "H5N1 infection of the respiratory tract and beyond: a molecular pathology study", Lancet, 370, pp.1137~1145 (2007)
11. Liem NT, "H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam", Jpn J Infect Dis, 61, pp.157~160 (2008)
12. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, "Update on avian influenza A (H5N1) virus infection in humans", N Engl J Med, 358, pp.261~273 (2008)
13. Suptawiwat O, "Enhanced susceptibility of nasal polyp tissues to avian and human inuenza viruses", PLoS One, 5, pp.e12973~ (2010)
14. Zhang Z, "Systemic infection of avian influenza A virus H5N1 subtype in humans", Hum Pathol, 40, pp.735~739 (2009)
15. Nicholls JM, "course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS", PLoS Med, 3, pp.e27~ (2006)
16. Imai Y, "Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury", Cell, 133, pp.235~249 (2008)
17. Hirst GK, "Adsorption of inuenza hemagglutinins and virus by red blood Cells", J Exp Med, 76, pp.195~209 (1942)
18. Varki A, "Sialic acids as ligands in recognition phenomena", FASEB J, 11, pp.248~255 (1997)
19. Varki NM, "Diversity in cell surface sialic acid presentations: implications for biology and disease", Lab Invest, 87, pp.851~857 (2007)
20. Air GM, "Influenza neuraminidase", Influenza Other Respi Viruses, 6, pp.245~256 (2012)
21. Rogers GN, "Receptor determinants of human and animal infiuenza virus isolates: diffrences in receptor specificity of the H3 hemagglutinin based on species of origin", Virology, 127, pp.361~373 (1983)
22. Baum LG, "Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity", Acta Histochem Suppl, 40, pp.35~38 (1990)
23. Scholtissek C, "The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses", Virology, 147, pp.287~294 (1985)
24. Vines A, "The role of infiuenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction", J Virol, 72, pp.7626~7631 (1998)
25. Trebbien R, "Distribution of sialic acidreceptors and infiuenza A virus of avian and swine origin in experimentally infected pigs", Virol J, 8, pp.434~ (2011)
26. Nelli RK, "Comparative distribution of human and avian type sialic acid infiuenza receptors in the pig", BMC Vet Res, 6, pp.4~ (2010)
27. Van Poucke SG, "Replication of avian, human and swine inuenza viruses in porcine respiratory explants and association with sialic acid distribution", Virol J, 7, pp.38~ (2010)
28. Voynow JA, "Mucins, mucus, and sputum", Chest, 135, pp.505~512 (2009)
29. Williams OW, "Airway mucus: From production to secretion", Am J Respir Cell Mol Biol, 34, pp.527~536 (2006)
30. Wheeler AH, "Effect of mucin on influenza virus infection in hamsters", Science, 96, pp.92~93 (1942)
31. Lo-Guidice JM, "Mucins secreted by a transformed cell line derived from human tracheal gland cells", Biochem J, 326, pp.431~437 (1997)
32. Couceiro JN, "Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity", Virus Res, 29, pp.155~165 (1993)
33. Nicholls JM, "Sialic acidreceptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian inuenza viruses", Respir Res, 8, pp.73~ (2007)
34. Ng WC, "Soluble host defense lectins in innate immunity to influenza virus", J Biomed Biotechnol, 2012, pp.732191~ (2012)
35. Basak S, "Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase", Virus Res, 2, pp.61~68 (1985)
36. Sun S, "Glycosylation site alteration in the evolution of influenza A (H1N1) viruses", PLoS One, 6, pp.22844~ (2011)
37. Reading PC, "Glycosylation as a target for recognition of inuenza viruses by the innate immune system", Adv Exp Med Biol, 598, pp.279~292 (2007)
38. Pritchett TJ, "Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin", J Biol Chem, 264, pp.9850~9858 (1989)
39. Kingma PS, "Correction of pulmonary abnormalities in Sftpd-", - mice requires the collagenous domain of surfactant protein D, 2006, pp.281, 24496~24505
40. Reading PC, "Increased susceptibility of diabetic mice to inuenza virus infection: compromise of collectin-mediated host defense of the lung by glucose", J Virol, 72, pp.6884~6887 (1998)
41. Ward KA, "Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009", Emerg Infect Dis, 17, pp.1409~1416 (2011)
42. Peiris JS, "Reemergence of fatal human inuenza A subtype H5N1 disease", Lancet, 363, pp.617~619 (2004)
43. Nicholls JM, "Tropism of avian inuenza A (H5N1) in the upper and lower respiratory tract", Nat Med, 13, pp.147~149 (2007)
44. Yu WC, "Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses", J Virol, 85, pp.6844~6855 (2011)
45. van Riel D, "Highlypathogenic avian influenza virus H5N1 infects alveolarmacrophages without virus production or excessive TNFalphainduction", PLoS Pathog, 7, pp.e1002099~ (2011)
46. Upham JP, "Macrophage receptors for influenza A virus: role of themacrophage galactose-type lectin and mannose receptor inviral entry", J Virol, 84, pp.3730~3737 (2010)
47. Hwang I, "Activationmechanisms of natural killer cells during influenzavirus infection", PLoS One, 7, pp.51858~ (2012)
48. Crouch E, "Collectins and pulmonaryinnate immunity", Immunol Rev, 173, pp.52~65 (2000)
49. Hillaire ML, "The number and position of N-linkedglycosylation sites in the hemagglutinin determine differentialrecognition of seasonal and 2009 pandemic H1N1influenza virus by porcine surfactant protein D", Virus Res, 169, pp.301~305 (2012)
50. van Riel D, "Human and avian influenzaviruses target dierent cells in the lower respiratory tract ofhumans and other mammals", Am J Pathol, 171, pp.1215~1223 (2007)
51. Weinheimer VK, "Influenza A virusestarget type II pneumocytes in the human lung", J InfectDis, 206, pp.1685~1694 (2012)
52. Hampton T, "Virulence of 1918 influenza virus linked to inflammatory innate immune response", JAMA, 297, pp.580~ (2007)
53. Chan MC, "Proinammatory cytokine responses induced by inuenzaA (H5N1) viruses in primary human alveolar and bronchialepithelial cells", Respir Res, 6, pp.135~ (2005)
54. van de Sandt CE, "Evasion ofinfluenza a viruses from innate and adaptive immune responses", Viruses, 4, pp.1438~1476 (2012)
55. Shinya K, "Toll-like receptorpre-stimulation protects mice against lethal infection withhighly pathogenic inuenza viruses", Virol J, 8, pp.97~ (2011)
56. Shinya K, "The TLR4-TRIF pathway protects against H5N1 influenza virus infection", J Virol, 86, pp.19~24 (2011)
57. Guillot L, "Involvement of toll-like receptor 3 in the immuneresponse of lung epithelial cells to double-strandedRNA and influenza A virus", J Biol Chem, 280, pp.5571~5580 (2005)
58. Jeisy-Scott V, "TLR7 recognition is dispensable for influenza virus Ainfection but important for the induction of hemagglutininspecific antibodies in response to the 2009 pandemic splitvaccine in mice", J Virol, 86, pp.10988~10998 (2012)
59. Bowzard JB, "PAMPer and tRIGer: ligand-inducedactivation of RIG-I", Trends Biochem Sci, 36, pp.314~319 (2011)
60. Wolff T, "Sabotage of antiviral signaling and effectors by influenzaviruses", Biol Chem, 389, pp.1299~1305 (2008)
61. Munir M, "TRIM proteins: another class of viral victims", SciSignal, 3, pp.jc2~ (2010)
62. Ramos I, "Cell receptors for influenzaa viruses and the innate immune response", Front Microbiol, 3, pp.117~ (2012)
63. Hornung V, "5'-Triphosphate RNA is the ligand for RIG-I", Science, 314, pp.994~997 (2006)
64. Pichlmair A, "RIG-I-mediated antiviral responsesto single-stranded RNA bearing 5'-phosphates", Science, 314, pp.997~1001 (2006)
65. Gack MU, "TRIM25 RINGfingerE3 ubiquitin ligase is essential for RIG-I-mediatedantiviral activity", Nature, 446, pp.916~920 (2007)
66. Ozato K, "TRIM familyproteins and their emerging roles in innate immunity", NatRev Immunol, 8, pp.849~860 (2008)
67. Steinberg BE, "Do viral infectionsmimic bacterial sepsis? The role of microvascular permeability:A review of mechanisms and methods", Antiviral Res, 93, pp.2~15 (2012)
68. Chan MC, "Inuenza H5N1 virus infectionof polarized human alveolar epithelial cells and lungmicrovascular endothelial cells", Respir Res, 10, pp.102~ (2009)
69. Iwasaki A, "A new shield for a cytokine storm", Cell, 146, pp.861~862 (2011)
70. Marsolais D, "A critical rolefor the sphingosine analog AAL-R in dampening the cytokineresponse during influenza virus infection", Proc NatlAcad Sci U S A, 106, pp.1560~1565 (2009)
71. Teijaro JR, "Endothelial cells are central orchestrators of cytokine amplifi-cation during influenza virus infection", Cell, 146, pp.980~991 (2011)
72. Walsh KB, "Quelling thestorm: utilization of sphingosine-1-phosphate receptorsignaling to ameliorate influenza virus-induced cytokinestorm", Immunol Res, 51, pp.15~25 (2011)
73. Kochs G, "Multipleanti-interferon actions of the influenza A virus NS1 protein", J Virol, 81, pp.7011~7021 (2007)
74. Garcia-Sastre A, "Influenza A virus lacking theNS1 gene replicates in interferon-deficient systems", Virology, 252, pp.324~330 (1998)
75. Li M, "Homology modeling and examination of theeffect of the D92E mutation on the H5N1 nonstructural proteinNS1 effctor domain", J Mol Model, 13, pp.1237~1244 (2007)
76. Garcia MA, "The dsRNA protein kinasePKR: virus and cell control", Biochimie, 89, pp.799~811 (2007)
77. Chen GW, "Genomic signaturesof human versus avian inuenza A viruses", EmergInfect Dis, 12, pp.1353~1360 (2006)
78. Jackson D, "Anew inuenza virus virulence determinant: the NS1 proteinfour C-terminal residues modulate pathogenicity", Proc NatlAcad Sci U S A, 105, pp.4381~4386 (2008)
79. Soubies SM, "Species-speciflccontribution of the four C-terminal amino acids of infiuenzaA virus NS1 protein to virulence", J Virol, 84, pp.6733~6747 (2010)
80. Soubies SM, "Deletionof the C-terminal ESEV domain of NS1 does not affect the replication of a low-pathogenic avian influenza virusH7N1 in ducks and chickens", J Gen Virol, 94, pp.50~58 (2013)
81. Fedson DS, "Confronting the next influenza pandemic withanti-inflammatory and immunomodulatory agents: whythey are needed and how they might work", Influenza OtherRespi Viruses, 3, pp.129~142 (2009)
82. Radigan KA, "The effect of rosuvastatin in a murine model ofinfluenza A infection", PLoS One, 7, pp.e35788~ (2012)
83. Tu W, "The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice", J Exp Med, 208, pp.1511~1522 (2011)
84. Szretter KJ, "Early control of H5N1 influenza virus replication by the type I interferon response in mice", J Virol, 83, pp.5825~5834 (2009)
85. Loutfy MR, "Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study", JAMA, 290, pp.3222~3228 (2003)
86. Van Hoeven N, "Pathogenesis of 1918 pandemic and H5N1 inuenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding", J Virol, 83, pp.2851~2861 (2009)
87. Kugel D, "Intranasal administration of alpha interferon reduces seasonal inuenza A virus morbidity in ferrets", J Virol, 83, pp.3843~3851 (2009)
88. Finter NB, "The use of interferon-alpha in virus infections", Drugs, 42, pp.749~765 (1991)
89. Herzog C, "Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled Theld study", Antiviral Res, 6, pp.171~176 (1986)
90. Jia D, "Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling", PLoS One, 5, pp.e13927~ (2010)

관련 논문AI추천